SCHEMBL17366292

SCHEMBL17366292

OBc1ccc(I)cc1F

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MAP2K2 P36507 2/20 0.33
▸ MAP2K1 Q02750 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12030950 0.82 MAP2K1 (0.33) MAP2K2MAP2K1
SCHEMBL17366279 0.77 IDO1 (0.30) —
SCHEMBL13107429 0.76 CES2 (0.43) —
SCHEMBL7097753 0.73 PPARG (0.38) —
SCHEMBL14140533 0.73 NFE2L2 (0.36) —
SCHEMBL29481423 0.69 — —
SCHEMBL80458 0.69 — —
SCHEMBL2038516 0.69 — —
Fluoride SCHEMBL25169957 0.67 CES2 (0.39) MAP2K2MAP2K1
SCHEMBL31621665 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588451-B1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INT (DE) 2015-12-30 — — EP disclosed
Send feedback